Citigroup Inc Vista Gen Therapeutics, Inc. Transaction History

Citigroup Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.12 - $0.3 $169 - $423	-1,410 Reduced 90.44%	149 $0
Q4 2022 Feb 09, 2023	SELL	$0.09 - $4.8 $126 - $6,724	-1,401 Reduced 47.33%	1,559 $0
Q3 2022 Nov 10, 2022	SELL	$0.14 - $4.8 $1,422 - $48,758	-10,158 Reduced 77.44%	2,960 $0
Q2 2022 Aug 10, 2022	BUY	$0.88 - $1.73 $5,206 - $10,234	5,916 Added 82.14%	13,118 $12,000
Q1 2022 May 12, 2022	SELL	$1.14 - $2.09 $462,081 - $847,150	-405,335 Reduced 98.25%	7,202 $9,000
Q4 2021 Feb 10, 2022	BUY	$1.67 - $2.76 $396,599 - $655,458	237,485 Added 135.67%	412,537 $804,000
Q3 2021 Nov 10, 2021	BUY	$2.62 - $3.45 $458,636 - $603,929	175,052 New	175,052 $480,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.